Annual Retained Earnings
-$248.62 M
-$10.49 M-4.41%
December 31, 2022
Summary
- As of February 10, 2025, NVIV annual retained earnings is -$248.62 million, with the most recent change of -$10.49 million (-4.41%) on December 31, 2022.
- During the last 3 years, NVIV annual retained earnings has fallen by -$29.46 million (-13.44%).
Performance
NVIV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$255.59 M
-$2.70 M-1.07%
September 30, 2023
Summary
- As of February 10, 2025, NVIV quarterly retained earnings is -$255.59 million, with the most recent change of -$2.70 million (-1.07%) on September 30, 2023.
- Over the past year, NVIV quarterly retained earnings has dropped by -$9.33 million (-3.79%).
Performance
NVIV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NVIV Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.4% | -3.8% |
| 3 y3 years | -13.4% | -13.1% |
| 5 y5 years | -35.2% | -24.8% |
NVIV Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +4.4% | at low | +7.3% | at low |
| 5 y | 5-year | +13.4% | at low | +16.6% | at low |
| alltime | all time | >+9999.0% | at low | >+9999.0% | at low |
InVivo Therapeutics Holdings Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$255.59 M(+1.1%) |
| Jun 2023 | - | -$252.89 M(+0.8%) |
| Mar 2023 | - | -$250.95 M(+0.9%) |
| Dec 2022 | -$248.62 M(+4.4%) | -$248.62 M(+1.0%) |
| Sep 2022 | - | -$246.26 M(+1.1%) |
| Jun 2022 | - | -$243.50 M(+1.1%) |
| Mar 2022 | - | -$240.78 M(+1.1%) |
| Dec 2021 | -$238.13 M(+4.3%) | -$238.13 M(+1.2%) |
| Sep 2021 | - | -$235.22 M(+1.1%) |
| Jun 2021 | - | -$232.77 M(+1.0%) |
| Mar 2021 | - | -$230.46 M(+1.0%) |
| Dec 2020 | -$228.23 M(+4.1%) | -$228.23 M(+1.0%) |
| Sep 2020 | - | -$226.04 M(+1.0%) |
| Jun 2020 | - | -$223.76 M(+1.0%) |
| Mar 2020 | - | -$221.57 M(+1.1%) |
| Dec 2019 | -$219.16 M(+5.7%) | -$219.16 M(+1.6%) |
| Sep 2019 | - | -$215.79 M(+1.3%) |
| Jun 2019 | - | -$213.11 M(+1.5%) |
| Mar 2019 | - | -$209.97 M(+1.3%) |
| Dec 2018 | -$207.33 M(+12.7%) | -$207.33 M(+1.2%) |
| Sep 2018 | - | -$204.81 M(+1.6%) |
| Jun 2018 | - | -$201.63 M(+6.9%) |
| Mar 2018 | - | -$188.69 M(+2.6%) |
| Dec 2017 | -$183.91 M(+17.1%) | -$183.91 M(+2.6%) |
| Sep 2017 | - | -$179.24 M(+5.5%) |
| Jun 2017 | - | -$169.89 M(+3.9%) |
| Mar 2017 | - | -$163.55 M(+4.2%) |
| Dec 2016 | -$157.01 M | -$157.01 M(+3.6%) |
| Sep 2016 | - | -$151.57 M(+4.3%) |
| Jun 2016 | - | -$145.38 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | -$140.19 M(+5.0%) |
| Dec 2015 | -$133.57 M(+33.2%) | -$133.57 M(+3.7%) |
| Sep 2015 | - | -$128.84 M(+1.8%) |
| Jun 2015 | - | -$126.53 M(+9.0%) |
| Mar 2015 | - | -$116.08 M(+15.8%) |
| Dec 2014 | -$100.25 M(+22.4%) | -$100.25 M(+9.1%) |
| Sep 2014 | - | -$91.87 M(+1.3%) |
| Jun 2014 | - | -$90.66 M(+4.2%) |
| Mar 2014 | - | -$87.01 M(+6.2%) |
| Dec 2013 | -$81.91 M(+89.8%) | -$81.91 M(+7.5%) |
| Sep 2013 | - | -$76.20 M(+7.7%) |
| Jun 2013 | - | -$70.77 M(+25.3%) |
| Mar 2013 | - | -$56.48 M(+30.9%) |
| Dec 2012 | -$43.15 M(-9.8%) | -$43.15 M(+25.3%) |
| Sep 2012 | - | -$34.44 M(-18.9%) |
| Jun 2012 | - | -$42.47 M(-4.9%) |
| Mar 2012 | - | -$44.67 M(-6.6%) |
| Dec 2011 | -$47.82 M(+265.3%) | -$47.82 M(+277.4%) |
| Sep 2011 | - | -$12.67 M(-19.5%) |
| Jun 2011 | - | -$15.74 M(+1.4%) |
| Mar 2011 | - | -$15.51 M(+1965.1%) |
| Dec 2010 | -$13.09 M(+1783.3%) | - |
| Sep 2010 | - | -$751.20 K(+3.8%) |
| Jun 2010 | - | -$723.90 K(+4.2%) |
| Mar 2010 | - | -$695.00 K(+9.8%) |
| Mar 2010 | -$695.00 K(+9.8%) | - |
| Mar 2009 | -$633.10 K(+11.3%) | -$633.10 K(+11.3%) |
| Mar 2008 | -$568.60 K(+6.7%) | -$568.60 K(+6.7%) |
| Mar 2007 | -$532.90 K | -$532.90 K(+250.1%) |
| Sep 2006 | - | -$152.20 K |
FAQ
- What is InVivo Therapeutics Holdings annual retained earnings?
- What is the all time high annual retained earnings for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings annual retained earnings year-on-year change?
- What is InVivo Therapeutics Holdings quarterly retained earnings?
- What is the all time high quarterly retained earnings for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings quarterly retained earnings year-on-year change?
What is InVivo Therapeutics Holdings annual retained earnings?
The current annual retained earnings of NVIV is -$248.62 M
What is the all time high annual retained earnings for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high annual retained earnings is -$532.90 K
What is InVivo Therapeutics Holdings annual retained earnings year-on-year change?
Over the past year, NVIV annual retained earnings has changed by -$10.49 M (-4.41%)
What is InVivo Therapeutics Holdings quarterly retained earnings?
The current quarterly retained earnings of NVIV is -$255.59 M
What is the all time high quarterly retained earnings for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high quarterly retained earnings is -$152.20 K
What is InVivo Therapeutics Holdings quarterly retained earnings year-on-year change?
Over the past year, NVIV quarterly retained earnings has changed by -$9.33 M (-3.79%)